JP2023521653A5 - - Google Patents

Info

Publication number
JP2023521653A5
JP2023521653A5 JP2022560074A JP2022560074A JP2023521653A5 JP 2023521653 A5 JP2023521653 A5 JP 2023521653A5 JP 2022560074 A JP2022560074 A JP 2022560074A JP 2022560074 A JP2022560074 A JP 2022560074A JP 2023521653 A5 JP2023521653 A5 JP 2023521653A5
Authority
JP
Japan
Prior art keywords
activator
taf
eng
polymer film
release rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521653A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/026135 external-priority patent/WO2021207329A1/en
Publication of JP2023521653A publication Critical patent/JP2023521653A/ja
Publication of JP2023521653A5 publication Critical patent/JP2023521653A5/ja
Pending legal-status Critical Current

Links

JP2022560074A 2020-04-07 2021-04-07 皮下用生分解性リザーバ装置のための多剤製剤 Pending JP2023521653A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063006163P 2020-04-07 2020-04-07
US63/006,163 2020-04-07
PCT/US2021/026135 WO2021207329A1 (en) 2020-04-07 2021-04-07 Multi-drug formulations for subcutaneous biodegradable reservoir device

Publications (2)

Publication Number Publication Date
JP2023521653A JP2023521653A (ja) 2023-05-25
JP2023521653A5 true JP2023521653A5 (https=) 2024-04-16

Family

ID=78023846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560074A Pending JP2023521653A (ja) 2020-04-07 2021-04-07 皮下用生分解性リザーバ装置のための多剤製剤

Country Status (10)

Country Link
US (1) US20230165788A1 (https=)
EP (1) EP4132465A4 (https=)
JP (1) JP2023521653A (https=)
KR (1) KR20220164785A (https=)
CN (1) CN115697304A (https=)
AU (1) AU2021252550A1 (https=)
CA (1) CA3174406A1 (https=)
IL (1) IL297145A (https=)
MX (1) MX2022012202A (https=)
WO (1) WO2021207329A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021268584A1 (en) * 2020-05-05 2022-12-01 Merck Sharp & Dohme Llc Drug delivery system for the delivery of antiviral agents and contraceptives
EP4358968A4 (en) * 2021-06-22 2025-05-07 Rome Therapeutics, Inc. 4-ETHINYL-3-HYDROXY-TETRAHYDROFURANYL ADENINE PHOSPHORAMIDATE AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
US20070275035A1 (en) * 2006-05-24 2007-11-29 Microchips, Inc. Minimally Invasive Medical Implant Devices for Controlled Drug Delivery
AU2010338425B2 (en) * 2009-12-21 2015-07-23 Janssen Sciences Ireland Uc Degradable removable implant for the sustained release of an active compound
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
US20180235900A1 (en) * 2017-02-06 2018-08-23 Research Triangle Institute Subcutaneous reservoir device and method of manufacture
JP7313438B2 (ja) * 2018-09-19 2023-07-24 ギリアード サイエンシーズ, インコーポレイテッド Hivの予防のためのインテグラーゼ阻害剤
MX2021003633A (es) * 2018-10-16 2021-05-27 Res Triangle Inst Dispositivo de depósito biodegradable subcutáneo.

Similar Documents

Publication Publication Date Title
Yoo et al. Phenomenology of the initial burst release of drugs from PLGA microparticles
Omidian et al. Chitosan nanoparticles for intranasal drug delivery
Hoffmann et al. Advances in orodispersible films for drug delivery
Salehi et al. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate
Wallis et al. 3D printing for enhanced drug delivery: current state-of-the-art and challenges
Jamróz et al. 3D printed orodispersible films with Aripiprazole
Lancina III et al. Chitosan nanofibers for transbuccal insulin delivery
CN102548535B (zh) 舌下和口腔用薄膜组合物
JP2023521653A5 (https=)
Bernards et al. Nanostructured thin film polymer devices for constant-rate protein delivery
Nagra et al. Feasibility of enhancing skin permeability of acyclovir through sterile topical lyophilized wafer on self-dissolving microneedle-treated skin
KR20190005198A (ko) 향상된 투과성을 가지는 약물학적 조성물
CN101321511A (zh) 递送活性剂的局部用薄膜组合物
CN102665762A (zh) 膜状药物剂型
CN105491997A (zh) 舌下及颊面膜组合物
JP2015528504A (ja) 抗疼痛及び抗嘔気及び/又は抗嘔吐組み合わせ組成物
Kim et al. Three-dimensional printing for oral pharmaceutical dosage forms
Tamaddon et al. Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis
Rosenberg et al. Anomalous release of hydrophilic drugs from poly (ϵ-caprolactone) matrices
Islam et al. Loratadine oral bioavailability enhancement via solid dispersion loaded oro-dispersible films: Formulation, characterization and pharmacokinetics
Arya et al. Role of 3D printing in pharmaceutical industry
JP2024088790A (ja) 多層マイクロニードルパッチ
EA038558B1 (ru) Водорастворимая фармацевтическая пленка с повышенной стабильностью
CN101346135A (zh) 用于活性剂递送的已调节pH的膜
CN118510494A (zh) 口腔微针贴片